Your browser doesn't support javascript.
loading
Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor.
Ben-Horin, S; Ungar, B; Kopylov, U; Lahat, A; Yavzori, M; Fudim, E; Picard, O; Peled, Y; Eliakim, R; Del Tedesco, E; Paul, S; Roblin, X.
Afiliação
  • Ben-Horin S; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Ungar B; First Affiliated Hospital of Sun-Yatsen University, Guangzhou, China.
  • Kopylov U; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Lahat A; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Yavzori M; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Fudim E; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Picard O; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Peled Y; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Eliakim R; Cardiology Department, Sheba Medical Center & Tel-Aviv University, Israel.
  • Del Tedesco E; Department of Gastroenterology, Sackler School of Medicine, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Tel Aviv, Israel.
  • Paul S; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
  • Roblin X; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Aliment Pharmacol Ther ; 47(8): 1117-1125, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29446098
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Fator de Necrose Tumoral alfa / Anticorpos Monoclonais Humanizados / Adalimumab / Infliximab Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Aliment Pharmacol Ther Assunto da revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Fator de Necrose Tumoral alfa / Anticorpos Monoclonais Humanizados / Adalimumab / Infliximab Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Aliment Pharmacol Ther Assunto da revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel